Cargando…
Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α
Oropharyngeal squamous cell cancer (OPC) accounts for 3% of all cancers and greater than 1.5% of all cancer deaths in the United States, with marked treatment-associated morbidity in survivors. More than 80% of OPC is caused by HPV16. Tumors induced by HPV have been linked to impaired immune functio...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681149/ https://www.ncbi.nlm.nih.gov/pubmed/36426368 http://dx.doi.org/10.3389/fimmu.2022.1011772 |
_version_ | 1784834554592231424 |
---|---|
author | DeVoti, James A. Israr, Mohd Lam, Fung Papayannakos, Christopher Frank, Douglas K. Kamdar, Dev P. Pereira, Lucio M. Abramson, Allan Steinberg, Bettie M. Bonagura, Vincent R. |
author_facet | DeVoti, James A. Israr, Mohd Lam, Fung Papayannakos, Christopher Frank, Douglas K. Kamdar, Dev P. Pereira, Lucio M. Abramson, Allan Steinberg, Bettie M. Bonagura, Vincent R. |
author_sort | DeVoti, James A. |
collection | PubMed |
description | Oropharyngeal squamous cell cancer (OPC) accounts for 3% of all cancers and greater than 1.5% of all cancer deaths in the United States, with marked treatment-associated morbidity in survivors. More than 80% of OPC is caused by HPV16. Tumors induced by HPV have been linked to impaired immune functions, with most studies focused on the local tumor microenvironment. Fewer studies have characterized the effects of these tumors on systemic responses in OPC, especially innate responses that drive subsequent adaptive responses, potentially creating feed-back loops favorable to the tumor. Here we report that elevated plasma levels of PGE(2) are expressed in half of patients with OPC secondary to overexpression of COX-2 by peripheral blood monocytes, and this expression is driven by IL-1α secreted by the tumors. Monocytes from patients are much more sensitive to the stimulation than monocytes from controls, suggesting the possibility of enhanced immune-modulating feed-back loops. Furthermore, control monocytes pre-exposed to PGE(2) overexpress COX-2 in response to IL-1α, simulating responses made by monocytes from some OPC patients. Disrupting the PGE(2)/IL-1α feed-back loop can have potential impact on targeted medical therapies. |
format | Online Article Text |
id | pubmed-9681149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96811492022-11-23 Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α DeVoti, James A. Israr, Mohd Lam, Fung Papayannakos, Christopher Frank, Douglas K. Kamdar, Dev P. Pereira, Lucio M. Abramson, Allan Steinberg, Bettie M. Bonagura, Vincent R. Front Immunol Immunology Oropharyngeal squamous cell cancer (OPC) accounts for 3% of all cancers and greater than 1.5% of all cancer deaths in the United States, with marked treatment-associated morbidity in survivors. More than 80% of OPC is caused by HPV16. Tumors induced by HPV have been linked to impaired immune functions, with most studies focused on the local tumor microenvironment. Fewer studies have characterized the effects of these tumors on systemic responses in OPC, especially innate responses that drive subsequent adaptive responses, potentially creating feed-back loops favorable to the tumor. Here we report that elevated plasma levels of PGE(2) are expressed in half of patients with OPC secondary to overexpression of COX-2 by peripheral blood monocytes, and this expression is driven by IL-1α secreted by the tumors. Monocytes from patients are much more sensitive to the stimulation than monocytes from controls, suggesting the possibility of enhanced immune-modulating feed-back loops. Furthermore, control monocytes pre-exposed to PGE(2) overexpress COX-2 in response to IL-1α, simulating responses made by monocytes from some OPC patients. Disrupting the PGE(2)/IL-1α feed-back loop can have potential impact on targeted medical therapies. Frontiers Media S.A. 2022-11-08 /pmc/articles/PMC9681149/ /pubmed/36426368 http://dx.doi.org/10.3389/fimmu.2022.1011772 Text en Copyright © 2022 DeVoti, Israr, Lam, Papayannakos, Frank, Kamdar, Pereira, Abramson, Steinberg and Bonagura https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology DeVoti, James A. Israr, Mohd Lam, Fung Papayannakos, Christopher Frank, Douglas K. Kamdar, Dev P. Pereira, Lucio M. Abramson, Allan Steinberg, Bettie M. Bonagura, Vincent R. Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α |
title | Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α |
title_full | Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α |
title_fullStr | Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α |
title_full_unstemmed | Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α |
title_short | Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α |
title_sort | oropharyngeal tumor cells induce cox-2 expression in peripheral blood monocytes by secretion of il-1α |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681149/ https://www.ncbi.nlm.nih.gov/pubmed/36426368 http://dx.doi.org/10.3389/fimmu.2022.1011772 |
work_keys_str_mv | AT devotijamesa oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT israrmohd oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT lamfung oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT papayannakoschristopher oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT frankdouglask oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT kamdardevp oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT pereiraluciom oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT abramsonallan oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT steinbergbettiem oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a AT bonaguravincentr oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a |